Royal Ottawa Healthcare Group, University of Ottawa Institute of Mental Health Research, Ottawa, ON K1Z 7K4, Canada.
Curr Opin Neurobiol. 2013 Feb;23(1):133-42. doi: 10.1016/j.conb.2012.08.004. Epub 2012 Sep 17.
Depression, conceptualized as major depressive disorder (MDD), is a complex psychiatric disorder with multiple behavioral changes and alterations in various brain regions. Biochemically, serotonin and others substances like GABA, glutamate, norepinephrin, adrenaline/noradrenaline play an essential role in the pathogenesis of MDD. The paper reviews recent human neuroimaging findings on how the genes underlying these biochemical substances modulate neural activity, behavior, and ultimately clinical symptoms. Current data provide solid evidence that genes related to serotonin impact emotion-related neural activity in the amygdala and the anterior cingulate cortex. By contrast, evidence is not as strong for genes related to biochemical substances other than serotonin and other regions of the brain. The review concludes with discussing future genetic, neural, and clinical challenges that point out the central role of gene × environment and brain × environment interactions as genetic and neural predispositions of depression.
抑郁症,概念化为重度抑郁症(MDD),是一种复杂的精神疾病,具有多种行为改变和各种脑区的改变。从生物化学角度来看,血清素和其他物质,如 GABA、谷氨酸、去甲肾上腺素/肾上腺素,在 MDD 的发病机制中起着重要作用。本文综述了最近关于这些生化物质的基因如何调节神经活动、行为以及最终临床症状的人类神经影像学研究结果。现有数据为与血清素相关的基因影响杏仁核和前扣带皮层的情绪相关神经活动提供了确凿的证据。相比之下,与除血清素以外的生化物质和大脑其他区域相关的基因的证据则不那么强。本文最后讨论了未来的遗传、神经和临床挑战,这些挑战指出了基因×环境和脑×环境相互作用作为抑郁症遗传和神经易感性的核心作用。